
Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer
Leonard Saltz, Suprith Badarinath, Shaker Dakhil, Bryan Bienvenu, W. Graydon Harker, George Birchfield, Laurence K. Tokaz, David Barrera, Paul R. Conkling, Mark A. O'Rourke, Donald A. Richards, DianeVolume:
11
Année:
2012
Langue:
english
Pages:
112
DOI:
10.1016/j.clcc.2011.05.006
Fichier:
PDF, 512 KB
english, 2012